TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action by Salazar, María et al.
[Autophagy 5:7, 1048-1049; 1 October 2009]; ©2009 Landes Bioscience
1048 Autophagy 2009; Vol. 5 Issue 7
Δ9-tetrahydrocannabinol (THC), the main active component 
of marijuana, is being investigated as a potential anti-tumoral 
agent. We find that THC stimulates an endoplasmic reticulum 
(ER) stress-related signaling pathway, which activates autophagy 
via inhibition of the Akt/mTORC1 axis. We also show that 
autophagy is upstream of apoptosis in cannabinoid-induced cancer 
cell death and that activation of this pathway is necessary for the 
anti-tumoral action of cannabinoids in vivo.
The final outcome of the activation of the autophagy program 
seems to be highly dependent on the cellular context and the 
strength and duration of the stress-inducing signals. Thus, besides 
its role in cellular homeostasis, autophagy can be a form of 
programmed cell death or play a cytoprotective role, for example 
in situations of nutrient starvation. Accordingly, autophagy plays 
a dual role in cancer. On one hand, this cellular process may help 
to overcome the stress evoked at the initial steps of tumorigenesis, 
and on the other, autophagy has been proposed to work as a tumor 
suppressor. Moreover, different anticancer treatments activate 
autophagy in tumor cells, which either enhance cancer cell death 
or act as a mechanism of resistance to chemotherapy.
Cannabinoids, the active components of marijuana, of which 
Δ9-tetrahydrocannabinol (THC) is the most important owing to 
its high abundance and potency, are currently being investigated 
as potential anti-tumoral agents. Along these lines, treatment with 
cannabinoids curbs tumor growth in various animal models of 
cancer. These anti-tumoral actions of cannabinoids are based on 
the ability of these agents to inhibit tumor angiogenesis and acti-
vate apoptosis of cancer cells.
Our recent findings have unraveled that cannabinoids induce 
autophagy in different types of tumor cells, including glioma/
astrocytoma and pancreatic cancer cells, whereas they do not 
activate this cellular process in nontransformed cells (which are 
resistant to the cell death-promoting activity of cannabinoids). 
Of interest, pharmacological or genetic inhibition of autophagy 
prevents cannabinoid-induced cell death as well as apoptosis, 
whereas abrogation of apoptosis prevents cell death but not 
autophagy as induced by these agents. These observations lead us 
to conclude that induction of autophagy is part of the mechanism 
by which cannabinoids promote the apoptotic death of cancer 
cells. The in vivo relevance of these findings is demonstrated by 
the observation that cannabinoid treatment reduces tumor growth 
and activates autophagy and apoptosis in subcutaneous tumor 
xenografts derived from human U87MG astrocytoma cells and 
transformed mouse embryonic fibroblasts (MEFs). Furthermore, 
autophagy-deficient tumors (generated by subcutaneous injection 
of transformed Atg5-/- MEFs) are resistant to THC anti-tumoral 
action, strongly supporting the idea that autophagy is essential for 
the antineoplastic activity of cannabinoids. In addition, analysis 
of samples obtained from two glioblastoma multiforme patients 
indicates that THC administration might also trigger autophagy-
mediated cell death in human tumors.
We also investigated the molecular mechanisms responsible 
for the activation of autophagy upon THC administration. Our 
results indicate that cannabinoids stimulate this process via an 
endoplasmic reticulum (ER) stress-related signaling pathway 
(Fig. 1). ER stress is an adaptive response that becomes activated 
in the cell when the ER is altered. We found that THC triggers 
*Correspondence to: Guillermo Velasco; Department of Biochemistry and 
Molecular Biology I; School of Biology; Complutense University; c/José Antonio 
Novais s/n; Madrid 28040 Spain; Tel.: +34.913944668; Fax: +34.913944672; 
Email: gvd@bbm1.ucm.es
Submitted: 06/12/09; Revised: 07/09/09; Accepted: 07/14/09
Previously published online as an Autophagy E-publication: 
http://www.landesbioscience.com/journals/autophagy/article/9508
Punctum to: Salazar M, Carracedo A, Salanueva IJ, Hernández-Tiedra S, Lorente 
M, Egia A, Vázquez P, Blázquez C, Torres S, García S, Nowak J, Fimia GM, 
Piacentini M, Cecconi F, Pandolfi PP, González-Feria L, Iovanna JL, Guzmán 
M, Boya P, Velasco G. Cannabinoid action induces autophagy-mediated cell 
death through stimulation of ER stress in human glioma cells. J Clin Invest 2009; 
119:1359–72; PMID: 19425170; DOI: 10.1172/JCI37948.
Autophagic Punctum
TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action
María Salazar,1,2 Arkaitz Carracedo,1,† Íñigo J. Salanueva,1 Sonia Hernández-Tiedra,1 Ainara Egia,1,† Mar Lorente,1,2 
Patricia Vázquez,3 Sofia Torres,1 Juan L. Iovanna,4 Manuel Guzmán,1,2 Patricia Boya3 and Guillermo Velasco1,2,*
1Department of Biochemistry and Molecular Biology I; School of Biology; Complutense University; Madrid, Spain; 2Centro de Investigación Biomédica en Red sobre 
Enfermedades Neurodegenerativas (CIBERNED); Madrid, Spain; 33D Lab (Development, Differentiation & Degeneration); Cellular and Molecular Medicine; Centro de 
Investigaciones Biológicas; CSIC; Madrid, Spain; 4U624 INSERM; Campus de Luminy; Marseille, France
†Present address: Cancer Genetics Program; Beth Israel Deaconess Cancer Center and Department of Medicine; Beth Israel Deaconess Medical Center; Harvard Medical 
School; Boston, MA USA
Abbreviations: Atg, autophagy-related; eIF2α, eukaryotic translation initiation factor 2α; ER, endoplasmic reticulum; mTORC1, 
mammalian target of rapamycin complex 1; THC, Δ9-tetrahydrocannabinol; TRB3, tribbles homologue 3
Key words: cancer, cannabinoids, autophagy, ER stress, TRB3
www.landesbioscience.com Autophagy 1049
an early accumulation of de novo-synthesized ceramide (an event 
that takes place in the ER), which leads in turn to ER dilation and 
increased eukaryotic initiation translation factor 2α (eIF2α) phos-
phorylation, two hallmarks of the ER stress response. Activation of 
this ER stress response induces the upregulation of several genes, 
including the stress-regulated protein p8 (also named candidate of 
metastasis 1, Com-1) and its downstream target, the pseudokinase 
Tribbles homologue 3 (TRB3), that we had previously implicated 
in cannabinoid anti-tumoral action. Genetic inhibition of p8 
and TRB3 prevents cannabinoid-induced autophagy as well as 
cell death, demonstrating that these proteins play a major role in 
connecting ER stress and autophagy in the context of cannabinoid 
action.
Our investigations show that a key step in the induction of 
autophagy by this ER stress-related signaling pathway relies on the 
inhibition of the Akt/mammalian target of rapamycin complex 1 
(mTORC1) axis by TRB3. It is widely accepted that one of the 
crucial events for the initiation of autophagy in many cellular 
settings is the inhibition of mTORC1, which plays a central role in 
the control of protein synthesis, cell growth and cell proliferation 
through the regulation of several downstream targets. In addi-
tion, mTORC1 is proposed to regulate autophagy by repressing 
the activity of Atg1. As a result of its central position in the 
control of cellular homeostasis, mTORC1 integrates signals from 
different inputs. One of the most important upstream regulators of 
mTORC1 is the pro-survival kinase Akt, which phosphorylates and 
inactivates TSC2 (an inhibitor of the mTORC1 activator Rheb) as 
well as PRAS40. Thus, Akt activation stimulates mTORC1 and 
inhibits autophagy.
In our study we found that cannabinoid treatment, via the 
above-described ER stress-related signaling route, increases TRB3 
levels and promotes the inhibitory interaction of this protein 
with Akt, leading in turn to mTORC1 inhibition. In agreement 
with these observations, treatment of mice with THC decreases 
mTORC1 activity, stimulates autophagy and apoptosis and reduces 
tumor growth in xenografts generated with p8+/+ cells but not in 
those generated with p8-/- cells (in which TRB3 is not upregu-
lated in response to THC), further confirming that the p8/TRB3 
pathway plays an essential role in the activation of autophagy and 
cell death by cannabinoids also in vivo.
As discussed above, research by different laboratories shows 
that autophagy is involved in both promotion and inhibition of 
tumor growth. However, the molecular determinants of this dual 
role of autophagy in cancer remain obscure. The identification by 
our laboratories of a new ER stress-related pathway that activates 
autophagy and promotes the apoptotic death of tumor cells may 
help to clarify the molecular events that lead to activation of 
autophagy-mediated cell death by anticancer drugs. The crucial 
role of p8 and TRB3 in cannabinoid anti-tumoral action points to 
these two proteins as important regulators of the autophagy process 
in the context of tumor cell death. Nevertheless, further research 
should still clarify whether the extent of ceramide accumulation, 
the simultaneous activation of other ER stress-regulated signaling 
pathways, the time frame and degree of mTORC1 inhibition, and 
the participation of specific autophagy genes are also key elements 
for the activation of the autophagy-mediated cell death pathway 
in tumor cells. Characterization of the molecular mechanisms that 
differentially regulate autophagy in situations in which this cellular 
process is activated to promote cell death will be crucial to design 
new therapeutic strategies based on the modulation of autophagy 
in cancer cells.
A new mechanism for activating autophagy-mediated cell death
Figure 1. Proposed mechanism of cannabinoid anti-tumoral action. This 
panel is modified from a schematic shown in Figure 7C of the original 
article published at J Clin Invest 2009; 119:1359–72.
